Site icon pharmaceutical daily

Pediatric Medicines Market 2020-2024 | Formulatory Advancement to Boost Growth | Technavio

LONDON–(BUSINESS WIRE)–#GlobalPediatricMedicinesMarket–Technavio has been monitoring the pediatric medicines market and it is poised to grow by USD 27.71 billion during 2020-2024, progressing at a CAGR of about 5% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.


Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request Free Sample Report on COVID-19 Impact

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Takeda Pharmaceutical Co. Ltd. are some of the major market participants. Formulatory advancement will offer immense growth opportunities. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Formulatory advancement has been instrumental in driving the growth of the market. (Read more…)

Pediatric Medicines Market 2020-2024: Segmentation

Pediatric Medicines Market is segmented as below:

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43146

Pediatric Medicines Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our pediatric medicines market report covers the following areas:

This study identifies inorganic growth strategies as one of the prime reasons driving the pediatric medicines market growth during the next few years.

Pediatric Medicines Market 2020-2024: Vendor Analysis

We provide a detailed analysis of vendors operating in the pediatric medicines market, including some of the vendors such as AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Takeda Pharmaceutical Co. Ltd. Backed with competitive intelligence and benchmarking, our research reports on the pediatric medicines market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Pediatric Medicines Market 2020-2024: Key Highlights

Table Of Contents:

Executive Summary

Market Landscape

Market Sizing

Five Forces Analysis

Market Segmentation by End-user

Customer landscape

Geographic Landscape

Drivers, Challenges, and Trends

Vendor Landscape

Vendor Analysis

Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: media@technavio.com
Website: www.technavio.com/

Exit mobile version